F10 and hemophilia: Such an analysis of the FX variants has resulted from three main advances as follows: (1) the availability of sufficient literature on FX genetic variants as the result of the increasing use of patient genotyping (Fig. 1); (2) the availability of a merged FXa crystal structure of a sufficient high quality for analyses (Methods); and (3) our increasing expertise in developing interactive databases related to hemophilia.23